Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:23:21.228Z.
Calculation as of: 2026-10-06T19:23:21.228Z.
Quote observation: 2026-10-06T19:19:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4553d85706fed5bac33927ddb0c45062b9ca990621471d16f8faa1ad8920ffc8
EARNINGS YIELD
N/A
Market Cap
$160.08M
Earnings Yield
N/A
TTM Avg
39.99%
3Y Avg
39.99%
5Y Avg
26.90%
Market Cap
$162.23M
Earnings Yield
N/A
TTM Avg
18.91%
3Y Avg
18.91%
5Y Avg
12.56%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PepGen Inc. (PEPG) | $159.44M | N/A | N/A | N/A | N/A |
| Minerva Neurosciences, Inc. (NERV)vs › | $160.08M | N/A | 39.99% | 39.99% | 26.90% |
| LifeMD, Inc. (LFMDP)vs › | $159.22M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $162.23M | N/A | 18.91% | 18.91% | 12.56% |
| Quanterix Corporation (QTRX)vs › | $162.58M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $156.90M | N/A | 1.53% | 2.27% | 1.64% |
| OptimizeRx Corp. (OPRX)vs › | $165.13M | 2.65% | 4.73% | 4.73% | 1.51% |
| Neuronetics, Inc. (STIM)vs › | $154.14M | N/A | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX)vs › | $165.63M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $152.82M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute